AVIR News and Press, Atea Pharmaceuticals Inc. From 05/10/22

The following slide deck was published by Atea Pharmaceuticals, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Atea Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation

Atea Pharmaceuticals press release (NASDAQ:AVIR): Q1 GAAP EPS of -$0.51 beats by $0.05. Cash and Cash Equivalents: $705.5 million at March 31, 2022 compared to $764.4 million at December 31, 2021 For further details see: Atea Pharmaceuticals GAAP EPS of -$0.51 beats by $0.05

New clinical results from MORNINGSKY trial shows 71% reduction in hospitalization (secondary endpoint) in broad patient population with COVID-19 treated with bemnifosbuvir (AT-527) versus placebo (p=0.047, unadjusted, exploratory) New clinical results from final analysis of Phase ...

BOSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that it will host a live conference call and audio webcast on Tuesday, May 10, 2022, at 8:00 a.m. ET to report financial res...

Shares of Atea Pharmaceuticals Inc. (NASDAQ:AVIR) traded today at $93.80, eclipsing its 52-week high. This new high was reached on above average trading volume as 62.4 million shares traded hands, while the average 30-day volume is approximately 993,000 shares. Atea Pharmaceuticals Inc i...

Shares of Atea Pharmaceuticals Inc. (NASDAQ:AVIR) traded today at $93.80, eclipsing its 52-week high. This new high was reached on above average trading volume as 62.3 million shares traded hands, while the average 30-day volume is approximately 1 million shares. Atea Pharmaceuticals Inc...

BOSTON, March 28, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today presented two posters highlighting nonclinical data demonstrating the nonclinical safety of bemnifosbuvir (AT-527) at the Society of...

Gainers: Incannex Healthcare Limited (NASDAQ:IXHL) +271%. Esperion Therapeutics (NASDAQ:ESPR) +10%. GitLab  (NASDAQ:GTLB) +9%. Niu Technologies (NASDAQ:NIU) +7%. Lordstown Motors  (NASDAQ:RIDE) +6%. Losers: Coupa Software Incorporated (NASDAQ:COUP) -29%. AnaptysB...

Atea Pharmaceuticals, Inc. (AVIR) Q4 2021 Earnings Conference Call February 28, 2022, 04:30 PM ET Company Participants Jonae Barnes - SVP, IR and Corporate Communications Jean-Pierre Sommadossi - Founder and CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO and EVP, Legal Jo...

Image source: The Motley Fool. Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q4 2021 Earnings Call Feb 28, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Atea Pharmaceuticals, Inc. (AVIR) Q4 2021 Earnings Call Transcri...